首页> 外文期刊>Pathology oncology research: POR >Dysregulation of microRNA Expression in Human Cervical Preneoplastic and Neoplastic Lesions
【24h】

Dysregulation of microRNA Expression in Human Cervical Preneoplastic and Neoplastic Lesions

机译:宫颈癌前病变和赘生性病变中microRNA表达的异常

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Data discussed in recent reviews demonstrated that dysregulation of microRNA (miRNA) expression profiles occurs during cervical carcinogenesis and characteristic up- or downregulation of certain miRNAs might be used as biomarkers. The majority of altered miRNAs, however were found to be inconsistent upon comparison with cancerous and normal cervical epithelia in the discussed studies due to several reasons. The results obtained in this present review suggest the need for further investigations on miRNAs on larger sample sizes in order to indicate sensitivity and specificity by means of well defined, "unified" methods. In addition, obtaining further data on the clinical course and outcome of patients in comparison to the dysregulation of miRNA expression profile could turn miRNAs into prognostic and/or progression markers. Inhibition of overexpressed miRNAs, as suggested by some authors, might even serve as target for cancer therapy.
机译:最近的评论中讨论的数据表明,在子宫颈癌的发生过程中会发生microRNA(miRNA)表达谱的失调,某些miRNA的特征性上调或下调可能被用作生物标记。然而,由于多种原因,在讨论的研究中与癌症和正常子宫颈上皮相比,发现大多数改变的miRNA是不一致的。在本综述中获得的结果表明,需要对更大样本量的miRNA进行进一步研究,以通过定义明确的“统一”方法表明敏感性和特异性。此外,与miRNA表达谱失调相比,获得有关患者临床病程和预后的进一步数据可能会将miRNA转变为预后和/或进展标志物。一些作者建议抑制过表达的miRNA甚至可能成为癌症治疗的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号